Soluble suppression of tumorigenicity-2 in cardiac amyloidosis, hypertrophic and dilated cardiomyopathy

Back

HFA Premium Access

Soluble suppression of tumorigenicity-2 in cardiac amyloidosis, hypertrophic and dilated cardiomyopathy

Session: Rapid Fire 7 - Improving our insights: biomarkers, imaging, scores

Topic: Clinical

Speaker: Doctor V. Castiglione (Pisa, IT)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Vincenzo Castiglione

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)

2 presentations

0 follower

14 more presentations in this session

Multiple patterns of left ventricular diastolic function and its determinants in cardiac amyloidosis: an updated evaluation according to ASE/EACVI 2016 guidelines

Speaker: Doctor S. Oghina (Creteil, FR)

High prevalence of cancer in patients with peripartum cardiomyopathy and potential pathophysiological connections

Speaker: Doctor T. Pfeffer (Hannover, DE)

Access

Abstract

After initial improvement, left ventricular ejection fraction remains stable in long-term survivors with dilated cardiomyopathy

Speaker: Ms A. Knutsen (Nordbyhagen, NO)

Clinical utility of the IMPACT score for mortality prediction after heart transplantation: external validation study.

Speaker: Doctor C. Ortiz-Bautista (Madrid, ES)

Genetic risk prediction of atrial fibrillation in a contemporary heart failure cohort

Speaker: Miss M. Kloosterman (Groningen, NL)

Access the full session

Rapid Fire 7 - Improving our insights: biomarkers, imaging, scores

Speakers: Doctor V. Castiglione, Doctor S. Oghina, Doctor T. Pfeffer, Ms A. Knutsen, Doctor C. Ortiz-Bautista...

Access

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources